The importance of biomarkers of post-myocardial infarction heart failure: a systematic review

Vásquez-Donet, Bazualdo-Fiorini, Saavedra-Alvarado, Portilla-Linares, Valdez-Portilla and Barrera-Benavides

Health Leadership and Quality of Life, 2023, vol. 2, 262

Abstract: Heart failure (HF) after a myocardial infarction (MI) is one of the most frequent complications and with the highest mortality rate in the population. Given this, the importance of finding appropriate biomarkers for the diagnosis, prognosis and treatment of this condition. The review was carried out under an analytical approach, using the PRISMA statement as a methodology; for this, documents were retrieved through the Scopus, ScienceDirect and PubMed databases, where 20 articles that met certain inclusion criteria were recognized. In conclusion, it was explained that the use of standard biomarkers such as B-type natriuretic peptide (BNP) and non-terminal pro-BNP in clinical practice have limitations, especially due to their low specificity for HF as a post-MI complication. Therefore, currently, biomarkers that reflect the alteration of cardiac integrity, biomarkers of cardiac injury and necrosis, inflammatory biomarkers, biomarkers of cardiac fibrosis, biomarkers of biomechanical myocardial stress, and other types of biomarkers such as non-coding RNAs are being investigated

Date: 2023
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:dbk:health:v:2:y:2023:i::p:262:id:262

DOI: 10.56294/hl2023262

Access Statistics for this article

More articles in Health Leadership and Quality of Life from AG Editor
Bibliographic data for series maintained by Javier Gonzalez-Argote ().